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ABSTRACT: Renibacterium salmoninarum, the causative agent of bacterial kidney disease, produces 
large quantities of a 57-58 kDa protein (p57) during growth in broth culture and during infection of 
salmonid fish. Biological activities of secreted p57 include agglutination of salrnonid leucocytes and 
rabbit erythrocytes. We define the location of epitopes on p57 recognized by agglutination-blocking 
monoclonal antibodies (MAbs) 4Cl1, 4H8 and 4D3, and demonstrate that the majority of secreted p57 
is a nlonomer that retains salrnonid leucocyte agglutinat~ng activity. The 3 MAbs bound a recombinant, 
amino-terminal fragment of p57 (211 aa) but not a carboxy-terminal fragment (315 aa) demonstrating 
that the neutralizing epitopes are located within the amino-terminal portion of p57. When combinations 
of the MAbs were used in an antigen capture ELISA. the epitopes recognized by the 3 MAbs were 
shown to be sterically separate. However, when the same MAb was used as both the coating and detec- 
tion MAb, binding of the biotinylated detection MAb was not observed. These data indicate that the 
epitopes recognized by the 3 agglutination-blocking antibodies are functionally available only once 
per molecule and that native p57 exists as a monomer Similar ELISA results were obtained when kid- 
ney tissues from 3 naturally infected chinook salmon were assayed. Finally, a p57 monomer was puri- 
fied using anion exchange and size exclusion chromatography that retained in vitro agglutinating 
activity. A model in which p57 is released from R. salmoninarum as a biologically active monomer 
during infection of salmonid fish is proposed. 
KEY WORDS: Bacterial kidney disease - Renibacterium salmoninarum . Monoclonal antibody 
Agglutination . Epitope 
INTRODUCTION 
Bacterial kidney disease is a chronic, systemic, gran- 
ulomatous, and often fatal disease prevalent among 
juvenile and adult salmonids (Fryer & Sanders 1981). 
Bacterial kidney disease is one of the most difficult 
bacterial diseases to control in salmonid aquaculture 
facilities due in part to 2 unusual pathogenic mecha- 
nisms of the causative agent, Renibacterium salmoni- 
narum (Elliott et al. 1989). First, R.  salmoninarum can 
'E-mail: wiensg@ohsu.edu 
"Present address: Department of Veterinary Medicine, 
National Chung Hsing University, 250 Kuo Kuang Road, 
Taichung, Taiwan 40227, ROC 
be vertically transmitted from female fish to offspring 
via intracellular infection of the egg (Evelyn et al. 1984, 
1986). Second, the bacterium can reside intracellularly 
within salmonid phagocytes and other host cells which 
may hinder immune clearance (Young & Chapman 
1978, Bruno & Munro 1986, Gutenberger et  al. 1997, 
McIntosh et  al. 1997). Little is known about the molec- 
ular mechanisms of pathogenesis or the host immune 
response (Evenden et al. 1993), however, this knowl- 
edge is crucial for the development of more efficacious 
therapeutics and vaccines. 
The best characterized virulence factor of Renibac- 
terium salmoninarum is a 57-58 kDa protein (p57). 
This protein is exposed on the bacterial cell surface of 
most strains and is also abundantly secreted by the 
bacteria during growth in culture media or infection of 
O Inter-Research 1999 
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MATERIALS AND METHODS 
fish (Getchell et  al. 1985, Turaga et al. 1987b, Wiens & subunit structure of p57 was also examined with fast 
Kaattari 1989, Rockey et al. 1991a, Bandin et al. 1992). pressure liquid chromatography (FPLC) and ELISA 
Cell-assoc~ated p57 has been reported to be necessary and we found that secreted p57 was present as a 
for virulence as spontaneous mutants of R. salmoni- monomer in culture supernatant as well as infected 
narum lacking cell-associated p57 were less virulent fish tissue. The monomer, purified from bacterial cul- 
upon intraperitoneal challenge (Bruno 1988, 1990). ture supernatant, was sufficient for agglutination of 
However, whether these mutants completely lack ex- rabbit erythrocytes and fish leucocytes in vitro. 
pression of p57 has been questioned (Grayson et al. 
1995). 
The function of secreted p57 in pathogenesis is 
unclear and sequence comparison with other proteins 
has so far been uninformative. P57 is a glycine rich, Animals. Rainbow trout Oncorhynchus mykiss were 
557 amino acid protein containing 2 copies of an  81 held in 12°C well water at  the Oregon State University 
residue direct repeat, which are 60% homologous, and Salmon Disease Laboratory and were fed Oregon 
5 copies of a second 25 residue imperfect repeat Moist Pellets (Bioproducts, Warrington, OR). Samples 
(Chien et al. 1992). One function of p57 may be to of infected ludney tissue were obtained from spawning 
mediate adherence of the bacteria to host tissues. P57 spring chinook salmon (0. tshawytscha) at  Marion 
has been reported to form a fimbrial structure on the Forks Hatchery, OR, and Carson Hatchery, WA, and 
bacterial cell surface and has a number of other char- homogenized as previously described (Rockey et al. 
acteristics of bacterial adhesins including haemagglu- 1991a). 
tinating activity, an  acidic isoelectric point, and hydro- Purification of MAbs. Cell-free ascites fluid from 
phobic amino acid composition (Jones & Isaacson 1983, group I MAbs (4Cl1, 4H8, and 4D3), group I1 MAbs 
Daly & Stevenson 1990, Dubreuil et al. 1990a, Wiens & (2G5 and 3H1) and group 111 MAbs (1Al and 4D10) 
Kaattari 1991). In vitro, the secreted form of p57 has were collected and purified by protein A chromatogra- 
immunomodulatory effects as it is able to bind and phy as described previously (Wiens & Kaattari 1991). 
agglutinate salmonid leucocytes and suppress anti- Protein content was determined by the method of 
body production to the unrelated antigens, trinitro- Lowry et al. (1951). 
phenylated lipopolysaccharide and human gamma- Extracellular protein (ECP) concentration. Renibac- 
globulin (Turaga et al. 1987a, Rockey et al. 1991b, and terium salmoninarum ATCC 33209 extracellular pro- 
Wiens & Kaattari 1991, Fredriksen et al. 1997). In addi- tein was harvested from medium and concentrated as 
tion, injection of coho salmon eggs with p57 has been described previously (Wiens & Kaattari 1991). The pre- 
reported to result in long term irnmunosuppression dominant component of ECP prepared in this manner 
(Brown et al. 1996). is p57 with associated proteolytic degradation frag- 
We have previously identified functional domains of ments (Rockey et al. 1991b, Wiens & Kaattari 1991). 
p57 using a panel of 8 anti-p57 monoclonal antibodies Total protein was assessed by the method of Lowry et 
(MAbs) (Wiens & Kaattari 1991). Three of the MAbs al. (1951) using bovine serum albumin (BSA, Sigma, St. 
(4D3, 4H8, and 4Cl l) inhibit haemagglutinating Louis, MO) as a standard. The ECP was filter-sterilized 
activity while 2 of these MAbs (4H8 and 4 C l l )  inhibit (0.45 pm) and stored at -70°C or kept at  4°C for imme- 
the leucoagglutinating activity of p57. The 3 agglutina- diate use. 
tion inhibiting MAbs, referred to as group I MAbs, ELISA. A capture ELISA was performed as described 
putativly recognize epitopes located on the amino- previously (Wiens & Kaattari 1989). Briefly, in this 
terminal third of p57, as determined by amino acid assay 5 pg ml-' MAbs 4D3. 4H8, 4Cl1, or polyclonal 
sequenclng of p57 and immunoblotting of partial p57 rabbit anti-ECP were separately coated onto the plate, 
proteolytic digests. Group I1 MAbs (3H1 and 2G5) non-specific sites blocked with 1 % BSA - 0.1 % 
recognize epitopes located in the central region of p57, Tween-Tris buffered saline (TTBS; 50 mM Tris, 1 mM 
while group I11 MAbs (1Al,4D10 and 2G9A) recognize EDTA, 8.7% NaCl, pH 8.0), and then 5 pg ml-' ECP in 
epitopes present in the carboxy-terminal third of p57 0.1 % TTBS was added. After washing the wells, 5 pg 
that are not exposed when intact p57 is attached to the ml-' of a biotinylated detection MAb was added as a 
Renibactenum salmoninarum cell surface. probe to screen for available epitopes on p57. Strepta- 
In this study, the functional domains of p57 were fur- vidin-horseradish peroxidase (Sigma) was then added 
ther defined. The group I MAbs recognized separate to determine the amount of bound biotinylated anti- 
non-overlapping epitopes in an enzyme linked im- body. To measure non-specific binding, biotinylated 
munosorbent assay (ELISA) and these epitopes were MOPC-21, a l g G , , ~  MAb of unknown specificity, was 
localized on the amino-terminal portion of p57 by used as a negative control (Sigma). Formalin-fixed 
irnmunoblotting of recombinant fragments of p57. The Renibacfenum salmoninarum cells were used as a 
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positive control to show that aggregates of p57 could 
be detected by the ELISA. R. salmoninarum cells were 
fixed for 12 h with 0.3 % formalin, washed 3x in phos- 
phate buffered saline (10 mM, PBS, pH 7.21, and 
resuspended at a concentration of 50 1-19 wet wt ml-' 
of 1 % BSA in 0.1 % TTBS. 
Purification of p57. FPLC was used to purify p57 
from ECP. Prior to FPLC, ECP was dialyzed in 50 mM 
phosphate buffer (pH 7.2) and filtered through a 0.2 pm 
low protein binding filter (Acrodisc 13, Gelman Sci- 
ences, Ann Arbor, MI). Approximately 3.9 mg of pro- 
tein was loaded onto a HR 5/5 Mono Q anion exchange 
column and eluted with a biphasic salt gradient of 0 to 
0.6 M NaC1, followed by 0.G to 1.0 M NaCl in 50 mM 
phosphate buffer (pH 7.2). One milliliter fractions from 
the anion exchange column were stored at -70°C until 
analyses were performed. A biphasic salt gradient 
eluted approximately 70% of the total protein in frac- 
tions 1 to 30 (see Fig. 3A). 
To determine the native molecular weight of p57, 
fraction 6 (75 pg total protein) from the anion exchange 
column was separated on a HR 10/30 Superose 12 
FPLC gel filtration column (10 X 30 cm, Pharmacia) 
using a buffer of 50 mM NaCl, 50 mM phosphate 
(pH 7.2) and 1 mM phenylmethylsulfonyl fluoride pro- 
tease inhibitor (PMSF). The peak absorbing fraction 
(15) from the gel filtration column was concentrated 
12-fold by ultrafiltration using a Centricon-3 (3000 MW 
cutoff, Amicon Division, Grace and Co., CT). 
Protease assay. The protease assay adapted from 
Sarath et al. (1989) used filter sterilized substrate solu- 
tion of 2 O/o azoalbumin (Sigma) in a 0.1 % sodium dode- 
cyl sulfate, 10 mM phosphate, 7.5% NaCl buffer 
(pH 7.2). Protease activity was determined by mixing 
30 p1 of each column fraction with 50 p1 of substrate at 
an incubation temperature of 37°C for 15 h. Intact sub- 
strate was precipitated with 200 p1 of 10% tnchloro- 
acetic acid for 15 min at room temperature. Samples 
were microfuged for 5 min, and 100 p1 of supernatant 
was transferred to ELISA wells to which 100 p1 1.0 M 
NaOH was added. The A,,, (absorbance at 450 nm) 
was determined using an EIA autoreader (Biotek 
Instruments, Burlington, VT). Units of activity were 
calculated from a log-log plot using trypsin (#T2271, 
Bovine Pancreas, Sigma) as a standard. 
Leucoagglutination and haemagglutination assays. 
Rainbow trout leucocytes and rabbit erythrocytes were 
prepared as previously described (Wiens & Kaattari 
1991), except that leucocytes were resuspended to a 
final concentration of 2 % autologous plasma (DeKon- 
ing & Kaattari 1991) instead of 10 % fetal bovine serum. 
Agglutination reactions worked equally well in either 
serum source. A total of 1.0 X 106 leucocytes well-' or 
1.5 X 106 erythrocytes well-' were mixed with 50 p1 of 
column fraction or 2-fold dilutions of each fraction. 
Agglutination was assessed after 24 h by microscopic 
examination. 
Construction and expression of recombinant, trun- 
cated p57 fragments. A 636 nt EcoRI to XhoI fragment 
encoding amino acids 32 to 243 of p57 was subcloned 
into PET-22b(+) (Novagen, Madison, WI). A second 
construct containing the carboxy-terminal amino acids 
242 to 557 was generated by PCR amplification with 
the reverse primer 5'-CGCGCTCGAGGTTAAAGGT- 
AATATCTAT and a forward primer 5'-CCGACAGC- 
AACTCTCGAGCCT. Hot start PCR amplification was 
carried out as recommended (Perkin Elmer, Norwalk, 
CT) using 5U of Ultma polymerase and 750 ng of target 
DNA. Twenty an~plification cycles (94"C, 30 S; 55"C, 
2 mini 72"C, 3 min) were followed by 10 min at 72°C. 
Following PCR, the product was purified and digested 
with XhoI and the 946 bp fragment subcloned into PET 
22b(+) expression vector and confirmed by sequenc- 
ing. Both constructs were expressed according to 
the protocol supplied with the pET22b(+) vector 
(Novagen). Briefly, the constructs were transformed 
into E. coli BL 21 and grown to an O.D. of 0.6 (600 nm). 
The expression of the His-tag fusion proteins was 
induced with 1 mM IPTG for 2 h.  Bacterial cells were 
washed in 50 mM Tris, pH 8.0,2 mM EDTA, and stored 
as a pellet at -70°C. Thawed cells were resuspended 
1:4 wt: v01 in 50 mM Tris, pH 8.0, 2 mM EDTA, and 
40 1.11 of this suspension was mixed with 10 p1 1 M DTT 
and 50 p1 2x SDS-PAGE sample buffer. Samples were 
boiled for 3 min, and sonicated for 2 s (Heat System 
Ultra Sonicator Inc.). Standard 10 or 12% SDS-PAGE 
and Western blotting were performed as previously 
described using the Mini-PROTEAN I1 system (Bio- 
Rad) (Wiens et al. 1990). 
RESULTS 
Epitope identification using group I MAbs 
In order to characterize the functional domains of 
p57 we used an antigen capture ELISA to determine if 
the epitopes recognized by the group I antibodies are 
distinct. Results from these experiments indicated that 
each of the 3 MAbs recognized spatially distinct 
epitopes (Fig. lA,B,C). For example, when 4D3 was 
coated onto wells, both heterologous biotinylated anti- 
bodies 4H8 (4H8-B), 4Cl l -B  as well as polyclonal 
rabbit antisera (RB-B) bound to p57, while the 
homologous antibody (4D3-B) and negative control 
MAb MOPC 21-B did not bind (Fig. 1A). Analogous 
results were obtained using the 4H8 and 4 C l l  MAbs 
(Fig. lB,C). Some binding of 4Cll-B to p57 captured 
by 4 C l l  was observed, but was apparently non- 
specific in nature as the level was similar to that ob- 
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served using the negative control antibody MOPC21-B. 
Equivalent activity of each biotinylated antibody was 
demonstrated by its binding to ECP coated wells 
(Fig. ID).  
Expression of a recombinant p57 
To independently localize the epitopes recognized 
by the group I MAbs, the amino-terminal portion of 
p57 and a carboxy-terminal portion of p57 were 
expressed in E. coli BL21 with a pel-B leader and His- 
tag (Fig. 2A). The amino terminal fragment, desig- 
nated p57.NH2, contained amino acids 32 to 243 and 
included amino acid repeat A l .  The carboxy-terminal 
fragment of p57, designated p57.COOH, contained 
amino acids 242 to 557 including amino acid repeat 
A2 and repeats B1-5. Expression of p57.NH2 and 
p57.COOH in E. coli was induced with IPTG and 
detected by Coomassie Blue staining of SDS-PAGE 
gels (Fig. 2B). MAb recognition of the recombinant 
proteins was assessed by immunoblotting. Group I 
MAb, 4H8, bound the amino-terminal fragment 
(Fig. 2B, lane 2), but not the carboxy-terminal fragment 
(lane 3).  MAbs 4C11 and 4D3 showed a similar binding 
pattern (data not shown). Lack of binding to the car- 
Coated with 4 D 3  
w . w  
4H8-B 4CI 1-6 4D3-B RE-E MOPC-B 
Capture Antibody 
Coated with 4 C l l  
2.07 
f i  
boxy-terminal fragment containing repeat A2 suggests 
that the group I antibodies do not recognize shared 
epitopes located on repeat A1 and A2. Conversely, 
group I1 (MAb 2G5) and group I11 (MAb 1Al) anti- 
bodies recognized epitopes on the carboxy-terminal 
fragment (Fig. 2B, lane 3) but not the amino-terminal 
fragment (lane 2). MAbs 3H1 and 4D10 showed a 
similar binding pattern (data not shown). The expres- 
sion of p57.COOH produced several immunoreactive 
bands that presumably represent proteolytic degrada- 
tion products consistent with the previously observed 
proteolysis of recombinant p57 expressed in E. coli 
(Grayson et al. 1995). 
Purification of p57 from culture supernatant and 
analysis of agglutinating activity 
To determine the subunit structure of p57 we used 
chromatographic methods to purify p57 from ECP. 
First, ECP was separated on an anion exchange mono- 
Q column. The majority of protein was eluted in the 
first 5 fractions as determined by absorbance at  280 nm 
(Fig. 3A). P57 was the major component eluting in 
fractions 5 through 14 as determined by total protein 
staining of transblotted proteins from SDS-PAGE gels 
Coated with 4H8 
2.0 , l 
Fig. 1. ELISA epitope analysis using 
combinations of arouD I MAbs. 4D3. 
" . V  4H8-B 4Cl l -B 4D3-B RB-B MOPC-B 4H8, and 4Cl l .  Antidody was coated 
Capture Antibody onto the ELISA plate at 5 pg mlF1 fol- 
lowed by 5 pg ml-' ECP diluted in 0.1 % 
Coated with ECP TTBS. Biotinylated detection MAbs 
2.0 , 
- 
(5 pg ml-l, MAb-B) were used to deter- 
mine the steric availabhty of epitopes. 
B~otinylated rabbit anti-ECP sera (RB-B) 
was used as a positive control, and bi- 
otinylated MAb MOPC 21 (MOPC-B) 
was used as a negative control to detect 
nonspecific binding. ECP was coated 
d~rectly onto the ELISA plate to de- 
termine maximal binding of each bi- 
otinylated antibody. After substrate 
was added, plates were incubated for 
30 rnin before AdOS was measured. Error 
bars denote standard deviations of 
u.u 4H8-B 4CI 1-6 4D3-B RB-B MOPC-B 
Capture Antibody 
".U 
4H8-B 4CI I-B 4D3-B RE-B MOPC-B tnplicate wells S d a r  results were 
Capture Antibody obtained in 3 separate experiments 
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(Fig. 3B). The identity of p57 in these fractions was 
further confirmed by Western blotting using MAb 1Al 
(Fig. 4B) and MAb 4D3 (not shown). Column frac- 
tions were also tested for haemagglutinating activity, 
proteolytic activity, and immunoreactivity by ELISA. 
Fractions 4 through 15 possessed haemagglutinating 
activity correlating with the elution of p57 (Fig. 4A). 
Proteolytic activity, detected by azoalbumin degrada- 
tion, was also observed in ECP and a major peak of 
activity eluted in fraction 3 prior to fractions in which 
the majority of p57 was found (Fig. 4A). In addition, 
minor amounts of proteolytic activity were observed in 
fractions 10 through 15. Proteolytic activity was un- 
detectable in fraction 6 which was used for further 
molecular weight characterization. 
To determine the native molecular weight of p57, 
75 pg of fraction 6 from the anion exchange column 
was subjected to superose size exclusion chromato- 
graphy. Dextran blue (30 pg) was included as an 
internal marker. Two peaks were detected by A280 
absorbance, the first peak was dextran blue at  7.5 m1 
and the second peak eluted at a peak of 14.3 m1 
A Repeat Regions 
1 A1 
NH2 COOH 
3 2 A1 2 4 3  p57.NH2 
2 4 2  A2 B1 82 B3 B4 85 5 5 7  
~ 5 7  COOH q n w  
B 4H8 2G5 1 A1 Coomassie 
Flg 2. (A) Linear depiction of native p57 protein including 
repeated regions. The larger repeat consists of two 81 
residues segments A1 and A2, and the smaller repeated 
sequence consists of 5 non-identical repeats of approxi- 
mately 25 residues each (B1 through B5). Two fragments of 
p57 were expressed from a PET-22b vector in E. coli strain 
BL21. An amino-terminal fragment from amino acid 32 to 
243 (p57.NH2) and a carboxy-fragment from amino acid 232 
to 557 (p57.COOH). (B) Immunoblots and Coomassie blue 
stain of recombinant proteins probed with either group I 
MAb 4H8, group I1 MAb 2G5, or group I11 MAb 1Al .  Lanes 
after the molecular weight markers are as follows: 1, 1 pg 
ECP. 2, p57.NH2, 3, p57.COOH, 4 ,  Induced E. coh control. 
Intact p57 is identified with an arrow 
0 5 10 15 20 25 30 35 
Fraction (ml) 
Fraction 
2 5 7 9 1 2 1 4  1 6 1 8 1 9 2 0 2 2 2 4 2 6  
' i 
Fig. 3. (A) FPLC anion-exchange chron~atography of concen- 
trated culture supernatant (ECP) from Renlbacterium sal- 
rnoninarum ATCC 33209. ECP (proteln content 3.9 mg) was 
applied to a anion-exchange Mono-Q column (HR 5/5) and 
eluted with a biphasic NaCl gradient in a 50 mM phosphate 
buffer (pH 7.2; flow rate 1 m1 m ~ n - ' ) .  The protein content of 
the eluent was detected photometrically at 280 nm with a UV 
monitor (solid line). A linear salt gradient of 0 to 600 mM was 
used to elute proteins from fraction 6 to 28 (dotted h e ) .  A 600 
to 1000 mM salt gradient was used from fraction 28 to 32. 
(B) Total protein stain of FPLC anion exchange column frac- 
tions 2 through 26. A total of 2.5 p1 of each fraction was 
electrophoresed through a 10% SDS polyacrylamide gel and 
electroblotted onto nitrocellulose and total protein detected 
with a collodial gold stain. The results are representative of 
2 experiments 
(Fig. 5A). The second peak contained p57 as deter- 
mined by a highly sensitive ELISA, and the majority of 
immunoreactivity eluted in fractions 14 through 17. 
Estimation of relative n~olecular weight of p57 using a 
panel of known proteins indicated that p57 eluted as 
a monomer with a calculated relative migration of 
46500 Da (Fig. 5B), as opposed to a dimer or multi- 
aggregated protein which should have eluted prior to 
fraction 13. Fraction 15 was further concentrated and 
subject to electrophoresis and immunoblotting (Fig. 6). 
P57 was purified to near homogeneity (Fig. 6,  lane 3), 
excluding a small amount of p45, as compared to the 
starting material (Fig. 6, lane 1). The minimum concen- 
tration required for agglutinating activity of rainbow 
trout leucocytes was decreased from 25 pg ml-' of the 
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A 1.2 ECP to 12.5 pg ml-' of purified p57 indicating an 
1.0 approximately 2-fold increase in act~vity. Agglutina- 
.- 
> 
.- 
c. 
tion of rabbit erythrocytes was also observed with puri- 
0 0.8 
m + 1Al fied p57. Agglutinating activity could be completely 0) 8 - 0.6 * Protease blocked with 100 pg ml-' MAb 4H8 confirming that 
5: agglutination was mediated by p57. E a 0.4 
E -  
- 
.- 0.2 Z 
0.0 Capture ELISA analysis of p57 in infected fish tissues 
0 5 10 15 20 25 30 35 
Fraction (ml) To investigate whether monomers of p57 were pre- 
sent in infected fish tissue, we performed capture 
ELISA analysis on kidney homogenates from naturally 
Fraction infected adult chinook salmon. Similar to the analysis B 
2 S 7 9 12 14 16 18 19 20 22 24 26 shown in Fig. 1, p57 captured by MAb 4D3 was not 
recognized by the homologous biotinylated MAb 4D3 
but was recognized by the heterologous MAb 4H8-B 
(Fig. 7). Formalin-fixed bacteria were used as a posi- 
tive control to demonstrate that the combination of 
MAb 4D3 and 4D3-B could detect aggregates of p57. It 
is unclear why MAb 4D3-B showed less binding to the 
formalin-fixed bacterial cells at  concentrations equiva- 
lent to those used with MAb 4H8-B, but perhaps this 
was due to steric hindrance from the coating MAb 4D3 
or destruction of epitopes by formalin. 
Fig. 4. Agglutinating, proteolytic, and irnrnunoreactive prop- DISCUSSION 
erties of the anion-exchange column fractions. (A) Fractions 
with agglutinating activity for rabbit erythrocytes are indi- To elucidate the molecular mechanisms of Renibac- 
cated with a +. Column fractions were coated onto ELISA terium salmoninarumpathogenesis, we utilized mouse 
wells and immunoreactivity probed with MAb 1 A l  (e). Pro- M A ~ ~  to characterize the structure and function of a 
teolytic activity against azoalbumin was measured as de- 
scribed in 'Materials and methods' (0). (B) Western blot of major cell surface and secreted protein, p57. In this 
column fractions using MAb 1 A l .  Intact p57 IS identified with study1 we extend our previous epitope map of ~5~ and 
an arrow investigate the m.echanism of cell agglutination. Previ- 
4D3 1 
Dextran Blue 
0 
0 
Fraction (ml) 
J 
Dextran Blue 
100: 
- 
_ _ _ _ _ _ _ _ - -  - 1 . CA 
10- 
Fraction (ml) 
Fig. 5. (A) Size exclusion chromatography of anion exchange fraction number 6 (75 pg), using a Superose 12 column. Dextran 
blue (30 pg) was included as an internal standard. (B) Relative migration of proteins vs log molecular weight markers. The column 
was equilibrated with 50 mM phosphate and 50 mM NaCl, pH 7.2, and Sigma standards were used to calibrate the column. Each 
point represents the average elution time and standard deviation calculated from 3 separate experiments. Standards included 
dextran blue (2  000 O O O ) ,  thryoglobulin (669 OOO), bovine serum albumin (66 OOO), ovalbumin (43 OOO), carbonic anhydrase (29 000) 
and cytochrome C (12400). The dashed Line represents the calculated molecular weight for p57. Identical results were obtained 
with 2 separate p57 preparations 
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Fig. 6 .  Immunoblot of column purified p57. The immunoblot 
was probed with 1 pg ml-' of a pool of purified MAbs 4D3, 
3H1, and 1Al. Primary MAb was detected by a 1:4000 goat 
anti-mouse Ig HRPO conjugate. The blot was developed with 
a chenlilunlinescent substrate (Amersham) and exposed to f~lm 
for 1 min. Lanes: 1, ECP, 1 pg; 2, 2.5 p1 of FPLC Mono-Q frac- 
tion 6;  3, 7.5 p1 of 12x concentrated Superose 12 fraction 15 
ously, we found that 3 MAbs, 4H8, 4 C l l  and 4D3, 
inhibit haemagglutinating activity while 2 of these 
MAbs, 4H8 and 4Cl l also inhibit the leucoagglutinat- 
ing activity of p57 (Wiens & Kaattari 1991). To deter- 
mine if these antibodies recognize the same or distinct 
epitopes on p57 we used a capture ELISA. In this 
Probed with: 
l .o 
4D3-B 
4H8-8 
U MOPC21-B 
V) 
0 
P 
a 0 5  
D D 
ECP RS Cells Fish 1 Fish 2 Fish 3 
Coated with MAb 4D3 
Fig. 7. ELISA epitope analysis of kidney tissue from 3 infected 
adult chinook salmon which were previously found to have 
antigen levels above 1 pg ml-' Plates were coated with 5 pg 
rnl-' 4D3, blocked with 1 % BSA-TTBS, and either 5 pg ml-' 
ECP, formalin-fixed Renibacterium sa1moninaru:n cells (50 pg 
ml-l), or a 1:100 dilution of kidney tissue homogenate added. 
ELISA plates were then probed with 5 pg ml-' detection MAbs 
4D3-B, 4H8-B or MOPC21-B. After substrate was added, 
plates were incubated for 10 min before was measured. 
Error bars denote standard deviations of triplicate wells 
assay, MAb 4D3, 4Cl l and 4H8 each recognized a dis- 
tinct epitope. The locations of the 4D3, 4H8 and 4 C l l  
epitopes were confirmed to lie between amino acids 32 
to 243 on p57 as all 3 of the MAbs bound the re- 
combinant, amino-terminal fragment, p57.NH2, but 
not to the carboxy-terminal fragment, p57.COOH, in a 
Western blot. These findings are consistent with our 
previous data showing that group I MAbs bind amino- 
terminal proteolytic fragments of p57 (Wiens & Kaat- 
tari 1991). Also consistent with our previous epitope 
map, group I1 MAbs (2G5 and 3Hl)  and group 111 
MAbs (1Al and 4D10) bound p57.COOH but not 
p57.NH2. The demonstration that the 3 group I MAbs 
recognized separate epitopes, and that these epitopes 
are separate from epitopes bound by the group I1 or 111 
antibodies, may have relevance for MAb-based im- 
munodiagnostic assays used to detect p57 in infected 
salmonids (Hsu et al. 1991, Rockey et al. 1991a). Inclu- 
sion of individual or combinations of these MAbs 
would increase the number of epitopes detected and 
may thereby increase the sensitivity of these ELISAs. 
The capture ELISA assay revealed an interesting 
aspect of the antigenic structure of p57. We observed 
that when the same MAb was used for both the coating 
and detection, binding of the biotinylated detection 
MAb was not observed. This was not due to a failure of 
the coating antibody to bind p57 because the heterolo- 
gous biotinylated MAbs and biotinylated rabbit poly- 
clonal antisera each bound well. This result was the 
same with each of the 3 group I MAbs suggesting that 
each epitope was functionally available only once per 
molecule of p57. These data are consistent with a 
monomer structure of p57. A dimer or aggregate of p57, 
containing 2 or more copies of the same epitope, would 
allow the simultaneous binding of both the homolo- 
gous coating and detecting antibody, providing that 
the epitopes are not masked by dimerization or aggre- 
gation. Our failure to detect binding when homologous 
MAbs were used was not due to an inability to detect 
aggregates of p57 as 4D3 and biotinylated 4D3 were 
able to bind formalin-fixed Renibacteriurn salmoni- 
narum cells that contain multiple copies of p57. The 
absence of repeated epitopes was surprising as Barton 
et al. (1997) have recently reported aggregation of p57 
occurred after separation by SDS-PAGE and elution 
with SDS and Triton X-100. In addition, we have ob- 
served MAb immunoreactive bands much larger than 
57 kDa in ECP preparations resolved under reducing 
SDS-PAGE conditions (Wiens & Kaattari 1991). It is 
possible that the capture ELISA assay was unable to 
detect small amounts of p57 aggregates in ECP, or per- 
haps denaturing conditions are necessary for aggre- 
gation. P57 has been described to form short, flexible, 
<2 nm diameter fimbriae that extend beyond the poly- 
saccharide capsule (Dubreuil et  al. 1990a,b). Presently, 
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the relationship between fimbrae, cell associated p57, 
and the secreted p57 in ECP is unclear. The monomers 
in ECP may result from proteolysis or unfolding of a 
dimer or multimer on the bacterial cell surface. 
To independently determine the native molecular 
weight of p57 in the absence of apparent denaturation, 
p57 was purified from ECP using ion-exchange and 
size exclusion chromatography. P57 was partially puri- 
fied and eluted with a M, of 46 500 consistent with a 
monomeric structure. The estimated relative molecular 
mass was smaller than the molecular mass of 54 505 Da 
calculated from the amino acid sequence of the mature 
protein (Chien et al. 1992). The reason for this discrep- 
ancy is unknown. A small amount of p45 breakdown 
product was present (Fig. 6, lane 3), however, the 
majority of p57 in our analysis appears identical to p57 
in unfractionated ECP by Western blot, suggesting 
that difference in migration was not due to extensive 
proteolysis during purification. Possibly p57 exhibits 
a compact structure under nondenaturing conditions. 
Secondary amino acid structure prediction supports 
this possibility as p57 is composed of predominatly 
beta-regions with little alpha-helix (unpubl. data). 
Since a number of agglutinins are multimeric struc- 
tures, yet p57 eluted as a monomer, the biological 
activity was tested in both haemagglutination and 
leucoagglutination assays. In vitro addition of the par- 
tially purified p57 monomer to rainbow trout leuco- 
cytes and rabbit erythrocytes was sufficient to cause 
agglutination and the activity was increased 2-fold by 
purification. The small increase in biological activity 
after purification was not unexpected as p57 is the 
major component of Renihactenum salmoninarum ECP 
(Getchell et al. 1985, Wiens & Kaattari 1991, Barton et 
al. 1997). The agglutinating activity was specific to p57 
as it was blocked by MAb 4H8. Interestingly, capture 
ELISA analysis suggested that a monomer was also the 
predominant from of p57 in kidney homogenates from 
3 naturally-infected adult chinook salmon. From these 
data we propose a model of p57 in which, at least 
initially, a monomer is sufficient to initiate agglutinat- 
ing activity and is released by R. salmoninarum during 
in vivo infection. 
Assuming that p57 agglutinates cells in a receptor- 
specific manner, we propose 3 potential mechanisms 
of p57 monomer-mediated agglutination. In the first 
mechainsm, p57 may initially be a monomer but may 
dimerize or aggregate after binding to a eucaryotic cell 
receptor. The binding site on p57 is likely located on 
the amino-terminal portion of p57 as MAbs that block 
agglutination bind this region. Once initial binding 
to the leucocyte occurs, the carboxy-region could be 
exposed. The exposed portions of p57 on adjacent 
leucocytes or erythrocytes might then dimerize or 
multimerize resulting in agglutination. While there is 
no direct evidence of the carboxy-region facilitating 
aggregation, p57 can aggregate after exposure to 
denaturing conditions (Barton et al. 1997). In, addition, 
secreted p57 is capable of reassembly onto the Reni- 
bacterium salmoninarum cell surface (Daly & Steven- 
son 1990, Piganelli et al. 1999a). The carboxy-terminal 
portion has been implicated in attachment to the bac- 
terial cell surface as partial proteolysis of p57 leaves 
carboxy-terminal fragments but not amino-terminal 
fragments associated with the bacterium (Wiens & 
Kaattari 1991). 
A second possible mechanism of monomer-mediated 
agglutination may be via proteolysis of host cell 
surface receptors. Haemagglutinins from both Vibrio 
cholerae and Pseudornonas aeruginosa have zinc/cal- 
cium dependent proteolytic activity that is able to 
modify erythrocyte surfaces and thereby induce agglu- 
tination (Hase & Finkelstein 1990). This mechanism 
requires p57 to posess proteolytic activity. Lynch and 
collegues have demonstrated that p57, and several 
lower molecular weight products of p57, continue to 
degrade during 2-dimensional electrophoretic separa- 
tion of ECP (Gnffiths & Lynch 1991, Barton et al. 1997). 
Furthermore, p57, and degradation products of p57 
isolated from the WC strain of Renibacterium salrnoni- 
narum, comigrate with PMSF-sensitive proteolytic 
activity detected by gelatin substrate gels. Taken 
together these results suggests that p57 is autoprote- 
olytic (Barton et al. 1997). Sequence analysis of p57 is 
consistent with this possibility as there is homology 
between the second repeated region of p57 and both 
trypsin-like and V8 staphylococcal-type serine pro- 
teases (Chien et al. 1992). In addition, a consensus 
serine protease motif G-X-S-X-G has been located 
from Gly-406 and Gly-4 10 between repeats B2 and B3 
(Fig. 2A) (Grayson et al. 1995). We however have pre- 
viously failed to detect autoproteolytic activity of p57 
purified by isoelectric focusing from the ATCC 33209 
and D6 strains (Rockey et al. 1991b), though as Barton 
et al. (1997) point out, this could be due to inactivation 
of proteolytic activity during isoelectric focusing. While 
we did not initially design these experiments to in- 
vestigate the autoproteolytic activity of p57, our main 
finding was that agglutinating activity did not elute 
with azoalbumin proteolytic activity suggesting that 
the azoalbumin proteolytic activity is a distinct mole- 
cule from p57. In addition, the agglutinating activity of 
ECP was not inhibited by PMSF or EDTA suggesting 
that neither serine nor divalent cation dependent pro- 
teolytic activity is required for agglutination (G. D. 
Wiens unpubl. data). The presence of a protease in 
ECP separate from p57 is consistent with our previous 
observations that ECP incubated at 37°C contains a 
molecule of >l00 kDa that is PMSF-sensitive with pro- 
teolytic activity but no detectable p57 (Rockey et al. 
Wiens et al.: Antigenic and f~ ~nctional characterization of p57 51 
1991). In addition, the n ~ o l e c u l e  having proteinase 
activity h a d  a n  isoelectric point be tween  6.5 a n d  7.5 
which is distinct from t h e  4.5 isoelectric point of p57 
(Rockey e t  al.  1991). In summary,  our  d a t a  a r g u e  
against  a protease dependent  model of agglutination, 
though the  role of the G-X-S-X-G serine protease motif 
in agglutination remains to b e  formally tested by site- 
directed mutagenesis.  
A third mechanism whereby  p57 agglut inates  cells 
m a y b e  via t h e  recognition a n d  cross-linking of differ- 
e n t  cellular receptors. It is possible that  2 separa te  
agglutinating domains exist, e a c h  specific for a sepa-  
rate  receptor. Results from t h e  an t igen  cap ture  ELISA 
provides potential evidence for this model  a s  MAbs  
4 C l l  a n d  4H8, which a r e  ab le  to  inhibit leucoaggluti- 
nat ing activity, bind to separa te  epitopes. Superant i -  
gens ,  many  which a r e  produced by Gram-positive bac- 
teria, have  such  bifunctional properties a n d  a r e  ab le  to 
bind a n d  crosslink both major histocompatibility class 
I1 molecules a n d  T cell receptors (Seth e t  al. 1994). P57 
is  unlike other superantigens from Gram-positive bac-  
teria as ,  to our knowledge,  superant igens from Gram-  
positive bacteria d o  not agglut inate  erythrocytes 
(Johnson e t  al.  1991). Support  for this mechanism 
awaits  analysis of t h e  mitogenic activity of purified p57 
a n d  the  identification of t h e  leucocyte surface recep-  
tor(s).  
In summary,  w e  demonstrate  that  agglutination-neu- 
tralizing group  I MAbs recognize separa te  epitopes on  
t h e  amino-terminal portion of p57 a n d  that  a monomer  
is t h e  predominant  subunit  s t ructure of p57 in E C P  a n d  
in infected fish tissue. T h e  role of t h e  monmeric  p57 in 
pathogensis is unclear. O n e  cellular target of p57 may 
b e  salmonid leukocytes where  it may  down regulate  
immune  function of t h e  salmonid host leading to a non-  
productive response. In support  of this possibility, p57 
inhibits specific antibody production in vitro (Turaga e t  
a l .  1987a, Rockey et  al.  1991b, a n d  Wiens & Kaattari 
1991, Fredriksen e t  a l .  1997) a n d  injection of p57 into 
coho salmon eggs  results in  long term immunosup- 
pression (Brown e t  al. 1996). T h e  presence  of bacterial 
cell-associated p57 is also likely to b e  critical in  
pathogensis a s  the  creation of p57- cells by the  activa- 
tion of a n  endogenous  PMSF-senstive protease leads 
to a n  increased humoral response toward carbohy- 
d ra te  moieties on  t h e  bacterial cell surface (Wood & 
Kaattari 1996, Piganelli e t  al. 1999a). In addition, 
results from preliminary vaccine trials using 37°C 
treated Renibacterium salmoninarum cells suggest  
that  t h e  removal of p57 is critical for t h e  induction of 
protective immunity in  salmonids (Piganelli e t  al.  
1999b). T h e  future analysis of p57  mutants  should 
facilitate t h e  characterization of functional domain(s) 
a n d  may clarify how the  presence of p57 impairs t h e  
development  of protective immunity in  salmonids. 
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